More on SPIROCOR noninvasive heart disease test: Second retraction (in fact the first) says little
Since we first wrote about the travails of Spirocor’s bedside, noninvasive test for coronary artery disease, we’ve been trying, without much success, to find out more information. But as they say about every dog, our day has come. As we initially reported, Ron Waksman, a prominent Washington, D.C. cardiologist and editor-in-chief of Cardiovascular and Revascularization … Continue reading More on SPIROCOR noninvasive heart disease test: Second retraction (in fact the first) says little